As Lilly rivalry flares, Novo CEO sets out Wegovy launch strategy
Go back to As Lilly rivalry flares, Novo CEO sets out Wegovy launch strategy| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1280.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1280.34 | 52 Week High | $88.16 | |||
| Open | $1280.34 | 52 Week Low | $67.88 | |||
| Day High | $1280.34 | P/E | 296.38 | |||
| Day Low | $1280.34 | EPS | $4.32 | |||
| Volume | 5,146 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.48 | 52 Week High | $59.00 | |||
| Open | $46.48 | 52 Week Low | $32.80 | |||
| Day High | $46.48 | P/E | N/A | |||
| Day Low | $46.48 | EPS | $0.00 | |||
| Volume | 58,961 | |||||

